You searched for London - Page 32 of 35

News and Trends 17 Sep 2020

3D Bioprinting Gains a Foothold in Biomedicine

…on multiple indications and multiple targets,” said Giuseppe Mazza, co-founder and CEO of the London-based firm Engitix. “Established pharmaceutical companies are not only accepting new ways to develop treatments but…

September 17, 2020 - 5 minutesmins - By Kostas Vavitsas

News and Trends 4 Jan 2017

This British Biotech is buying its way into the Crowded NASH Space

Tiziana Life Sciences is acquiring candidates to gain leverage in the profitable NASH market, where there’s currently a fierce competition. Tiziana Life Sciences, a biopharmaceutical company from London, is…

January 4, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 28 Feb 2017

It’s Global Rare Disease Day! What Cures is Biotech Cooking Up?

…in London, is also developing an ex vivo autologous gene therapy for ADA-SCID. This type of therapy makes genetic modifications in the target cells outside the body instead of delivering…

February 28, 2017 - 5 minutesmins - By Clara Rodríguez Fernández

mRNA DNA race Covid 19 vaccine BioNTech Pfizer

News and Trends 22 Dec 2020

EMA Greenlights BioNTech and Pfizer mRNA Vaccine for Covid-19

…are in with smallpox (gone), polio (almost gone), or measles (controlled in populations with high enough vaccine coverage),” wrote Liam Smeeth, Professor at the London School of Hygiene and Tropical…

December 22, 2020 - 5 minutesmins - By Jonathan Smith

boehringer ingelheim cancer vaccine amal therapeutics

News and Trends 10 Apr 2020

Coronavirus Pandemic Bites into European Cancer Research

…events such as the London Marathon being postponed. The organization, which funds nearly half the UK’s cancer research, will cut up to 10% off support to existing grants and institutes…

April 10, 2020 - 4 minutesmins - By Anita Chakraverty

Best in Biotech 20 Dec 2021

The Billion-Euro European Biotech Companies in 2022

…London Stock Exchange, where it raised over €400M on the very first day. Analysts are now seeing it as a European alternative to US company Illumina, which markets one of…

December 20, 2021 - 12 minutesmins - By Larissa Warneck-Silvestrin

News and Trends 23 Oct 2017

A Peptide Reduces Bleeding in Surgery in Phase II Trials

…European hospitals, London-based Ergomed has demonstrated that itspipeline’s lead candidate, PeproStat, can reduce the time to achieve hemostasis, that is, for the bleeding to stop, during surgery as compared to…

October 23, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Circassia failure AstraZeneca deal cover

News and Trends 17 Mar 2017

Can this British Biotech Overcome Failure buying drugs from AstraZeneca?

…raised an impressive £200M (€230) when it entered the London Stock Exchange. The catastrophe of its cat allergy trial has definitely made the company fall short of expectations. Notably, the…

March 17, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 9 Oct 2018

Hormone Therapy for Inherited Hormonal Disorder Fails at Phase III

…on the morning of the release, with the company’s stock prices falling by around 60% when the London Stock Exchange opened. These results were an unexpected setback for the company,…

October 9, 2018 - 3 minutesmins - By Jonathan Smith

Opinion 1 Nov 2023

Could this be the start of a new era for PI3K drugs?

…signals. Prof Bart Vanhaesebroeck, professor of Cell Signalling at the University College London (UCL) Cancer Institute in the U.K., pointed to research that suggests PI3K inhibitors shouldn’t be thought of…

November 1, 2023 - 7 minutesmins - By External Contributor

News and Trends 1 Dec 2016

It’s World AIDS Day, is Biotech close to an HIV Cure?

…at Imperial College London could reduce diagnostic time from 3 days to under 30 minutes: https://www.labiotech.eu/medical/hiv-diagnostic-chip-usb/ Scientific Challenges One of the main drawbacks when treating HIV is the rapid evolution…

December 1, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 9 May 2023

Gene & cell therapy manufacturer Ascend launches with more than $130M

…is headquartered in the U.K. with GMP production in Potters Bar, North London. There is also platform technology research in the San Francisco Bay area in the U.S., and a…

May 9, 2023 - 2 minutesmins - By Jim Cornall

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: London

3D Bioprinting Gains a Foothold in Biomedicine

This British Biotech is buying its way into the Crowded NASH Space

It’s Global Rare Disease Day! What Cures is Biotech Cooking Up?

EMA Greenlights BioNTech and Pfizer mRNA Vaccine for Covid-19

Coronavirus Pandemic Bites into European Cancer Research

The Billion-Euro European Biotech Companies in 2022

A Peptide Reduces Bleeding in Surgery in Phase II Trials

Can this British Biotech Overcome Failure buying drugs from AstraZeneca?

Hormone Therapy for Inherited Hormonal Disorder Fails at Phase III

Could this be the start of a new era for PI3K drugs?

It’s World AIDS Day, is Biotech close to an HIV Cure?

Gene & cell therapy manufacturer Ascend launches with more than $130M

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!